Sen. Blumenthal Requests GAO Investigation of Drug Shortages

Sen. Richard Blumenthal (D-Conn.) has requested an investigation of drug shortages in a letter to the Government Accountability Office, according to an ASA release.

Advertisement

In his letter, Sen. Blumenthal requests GAO to “examine the extent of hospital shortages of pharmaceutical products and the prevalence of these shortages in recent years,” as well as “the impact of such shortages on patient care, possible explanations and potential legislative or administrative approaches to addressing this problem.”

Read Sen. Blumenthal’s letter to the GAO.

Read the ASA release on Sen. Blumenthal’s letter.

Read more on anesthesia:

Changes to Epidural Doses Allow Movement Without Pain

Anesthesiologist on the Move: Dr. Suwarna Bhide Deoskar Joins Essentia Health

Drug Shortages Force California Facilities to Look for Alternatives

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.